APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Primaquine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Primaquine Market Outlook and Growth Opportunities 2026

Report ID 174028450426 December 2025196 pages

Choose your research edition.

Industry ResearchPrimaquine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Primaquine Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Primaquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primaquine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Primaquine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Primaquine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Primaquine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Primaquine market include Cyper Pharma, Santa Cruz Biotechnology, Summit Medical Group and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Primaquine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Primaquine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Primaquine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Primaquine market size, projected growth trends, production technologies, key applications, and end-use industries.

Primaquine Segment by Company

Cyper Pharma

Santa Cruz Biotechnology

Summit Medical Group

Pfizer

Primaquine Segment by Type

Injectables Primaquine

Tablets Primaquine

Capsules Primaquine

Primaquine Segment by Application

Laboratory

Hospital

Clinic

Others

Primaquine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Primaquine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Primaquine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Primaquine significant trends, drivers, influence factors in global and regions.

6. To analyze Primaquine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primaquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Primaquine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Primaquine industry.

Chapter 3: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Primaquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Primaquine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Primaquine Industry Trends Table 2. Primaquine Industry Drivers Table 3. Primaquine Industry Opportunities and Challenges Table 4. Primaquine Industry Restraints Table 5. Global Primaquine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Primaquine Revenue Share by Company (2021-2026) Table 7. Global Primaquine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Primaquine Sales Volume Share by Company (2021-2026) Table 9. Global Primaquine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Primaquine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Primaquine Key Company Manufacturing Base & Headquarters Table 12. Global Primaquine Company, Product Type & Application Table 13. Global Primaquine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Primaquine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injectables Primaquine Table 18. Significant Companies of Tablets Primaquine Table 19. Significant Companies of Capsules Primaquine Table 20. Global Primaquine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Primaquine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Primaquine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Primaquine Sales Volume Share by Type (2021-2026) Table 24. Global Primaquine Sales Volume Share by Type (2027-2032) Table 25. Global Primaquine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Primaquine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Primaquine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Primaquine Sales Value Share by Type (2021-2026) Table 29. Global Primaquine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Laboratory Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Primaquine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Primaquine Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Primaquine Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Primaquine Sales Volume Share by Application (2021-2026) Table 38. Global Primaquine Sales Volume Share by Application (2027-2032) Table 39. Global Primaquine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Primaquine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Primaquine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Primaquine Sales Value Share by Application (2021-2026) Table 43. Global Primaquine Sales Value Share by Application (2027-2032) Table 44. Global Primaquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Primaquine Sales by Region (2021-2026) & (K Units) Table 46. Global Primaquine Sales Market Share by Region (2021-2026) Table 47. Global Primaquine Sales by Region (2027-2032) & (K Units) Table 48. Global Primaquine Sales Market Share by Region (2027-2032) Table 49. Global Primaquine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Primaquine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Primaquine Sales Value Share by Region (2021-2026) Table 52. Global Primaquine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Primaquine Sales Value Share by Region (2027-2032) Table 54. Global Primaquine Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Primaquine Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Primaquine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Primaquine Sales by Country (2021-2026) & (K Units) Table 59. Global Primaquine Sales Market Share by Country (2021-2026) Table 60. Global Primaquine Sales by Country (2027-2032) & (K Units) Table 61. Global Primaquine Sales Market Share by Country (2027-2032) Table 62. Global Primaquine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Primaquine Sales Value Market Share by Country (2021-2026) Table 64. Global Primaquine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Primaquine Sales Value Market Share by Country (2027-2032) Table 66. Cyper Pharma Company Information Table 67. Cyper Pharma Business Overview Table 68. Cyper Pharma Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Cyper Pharma Primaquine Product Portfolio Table 70. Cyper Pharma Recent Development Table 71. Santa Cruz Biotechnology Company Information Table 72. Santa Cruz Biotechnology Business Overview Table 73. Santa Cruz Biotechnology Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Santa Cruz Biotechnology Primaquine Product Portfolio Table 75. Santa Cruz Biotechnology Recent Development Table 76. Summit Medical Group Company Information Table 77. Summit Medical Group Business Overview Table 78. Summit Medical Group Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Summit Medical Group Primaquine Product Portfolio Table 80. Summit Medical Group Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Primaquine Product Portfolio Table 85. Pfizer Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Primaquine Distributors List Table 89. Primaquine Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Primaquine Product Image Figure 2. Global Primaquine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primaquine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Primaquine Sales (2021-2032) & (K Units) Figure 5. Global Primaquine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Primaquine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injectables Primaquine Image Figure 10. Tablets Primaquine Image Figure 11. Capsules Primaquine Image Figure 12. Global Primaquine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Primaquine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Primaquine Sales Volume Share by Type (2021-2032) Figure 15. Global Primaquine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Primaquine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Primaquine Sales Value Share by Type (2021-2032) Figure 18. Laboratory Image Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Primaquine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Primaquine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Primaquine Sales Volume Share by Application (2021-2032) Figure 25. Global Primaquine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Primaquine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Primaquine Sales Value Share by Application (2021-2032) Figure 28. Global Primaquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Primaquine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Primaquine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Primaquine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Primaquine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Primaquine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Primaquine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Primaquine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Primaquine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Primaquine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Primaquine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Primaquine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Primaquine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Primaquine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Primaquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Primaquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Primaquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Primaquine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Primaquine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables Primaquine
  • Tablets Primaquine
  • Capsules Primaquine
Applications
  • Laboratory
  • Hospital
  • Clinic
  • Others
Companies covered
  • Cyper Pharma
  • Santa Cruz Biotechnology
  • Summit Medical Group
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Primaquine Sales Value (2021-2032)
  4. 1.2.2 Global Primaquine Sales Volume (2021-2032)
  5. 1.2.3 Global Primaquine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Primaquine Market Dynamics
  1. 2.1 Primaquine Industry Trends
  2. 2.2 Primaquine Industry Drivers
  3. 2.3 Primaquine Industry Opportunities and Challenges
  4. 2.4 Primaquine Industry Restraints
3 Primaquine Market by Company
  1. 3.1 Global Primaquine Company Revenue Ranking in 2025
  2. 3.2 Global Primaquine Revenue by Company (2021-2026)
  3. 3.3 Global Primaquine Sales Volume by Company (2021-2026)
  4. 3.4 Global Primaquine Average Price by Company (2021-2026)
  5. 3.5 Global Primaquine Company Ranking (2024-2026)
  6. 3.6 Global Primaquine Company Manufacturing Base and Headquarters
  7. 3.7 Global Primaquine Company Product Type and Application
  8. 3.8 Global Primaquine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Primaquine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Primaquine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Primaquine Market by Type
  1. 4.1 Primaquine Type Introduction
  2. 4.1.1 Injectables Primaquine
  3. 4.1.2 Tablets Primaquine
  4. 4.1.3 Capsules Primaquine
  5. 4.2 Global Primaquine Sales Volume by Type
  6. 4.2.1 Global Primaquine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Primaquine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Primaquine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Primaquine Sales Value by Type
  10. 4.3.1 Global Primaquine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Primaquine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Primaquine Sales Value Share by Type (2021-2032)
5 Primaquine Market by Application
  1. 5.1 Primaquine Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Others
  6. 5.2 Global Primaquine Sales Volume by Application
  7. 5.2.1 Global Primaquine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Primaquine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Primaquine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Primaquine Sales Value by Application
  11. 5.3.1 Global Primaquine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Primaquine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Primaquine Sales Value Share by Application (2021-2032)
6 Primaquine Regional Sales and Value Analysis
  1. 6.1 Global Primaquine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Primaquine Sales by Region (2021-2032)
  3. 6.2.1 Global Primaquine Sales by Region: 2021-2026
  4. 6.2.2 Global Primaquine Sales by Region (2027-2032)
  5. 6.3 Global Primaquine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Primaquine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Primaquine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Primaquine Sales Value by Region (2027-2032)
  9. 6.5 Global Primaquine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Primaquine Sales Value (2021-2032)
  12. 6.6.2 North America Primaquine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Primaquine Sales Value (2021-2032)
  15. 6.7.2 Europe Primaquine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Primaquine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Primaquine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Primaquine Sales Value (2021-2032)
  21. 6.9.2 South America Primaquine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Primaquine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Primaquine Sales Value Share by Country, 2025 VS 2032
7 Primaquine Country-level Sales and Value Analysis
  1. 7.1 Global Primaquine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Primaquine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Primaquine Sales by Country (2021-2032)
  4. 7.3.1 Global Primaquine Sales by Country (2021-2026)
  5. 7.3.2 Global Primaquine Sales by Country (2027-2032)
  6. 7.4 Global Primaquine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Primaquine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Primaquine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Primaquine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Primaquine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Primaquine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Primaquine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Primaquine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Primaquine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Primaquine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Primaquine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Primaquine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Primaquine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Primaquine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Primaquine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Primaquine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Primaquine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Primaquine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Primaquine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Primaquine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Primaquine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Primaquine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Primaquine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Primaquine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Primaquine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Primaquine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Primaquine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Primaquine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Primaquine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Primaquine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Primaquine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Primaquine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Primaquine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Primaquine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Primaquine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Primaquine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Primaquine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Primaquine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Primaquine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Primaquine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Primaquine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Primaquine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Primaquine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Primaquine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Primaquine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Primaquine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Primaquine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Primaquine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Primaquine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Primaquine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Primaquine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Primaquine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Primaquine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Primaquine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Primaquine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Primaquine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Primaquine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Primaquine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Primaquine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Primaquine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Primaquine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Primaquine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Primaquine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Primaquine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Primaquine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Primaquine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Primaquine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Primaquine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Primaquine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Primaquine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Primaquine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Primaquine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Primaquine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Primaquine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Primaquine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Primaquine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Primaquine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Primaquine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Primaquine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Primaquine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Primaquine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Primaquine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Primaquine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Primaquine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Primaquine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Primaquine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Primaquine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cyper Pharma
  2. 8.1.1 Cyper Pharma Company Information
  3. 8.1.2 Cyper Pharma Business Overview
  4. 8.1.3 Cyper Pharma Primaquine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cyper Pharma Primaquine Product Portfolio
  6. 8.1.5 Cyper Pharma Recent Developments
  7. 8.2 Santa Cruz Biotechnology
  8. 8.2.1 Santa Cruz Biotechnology Company Information
  9. 8.2.2 Santa Cruz Biotechnology Business Overview
  10. 8.2.3 Santa Cruz Biotechnology Primaquine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Santa Cruz Biotechnology Primaquine Product Portfolio
  12. 8.2.5 Santa Cruz Biotechnology Recent Developments
  13. 8.3 Summit Medical Group
  14. 8.3.1 Summit Medical Group Company Information
  15. 8.3.2 Summit Medical Group Business Overview
  16. 8.3.3 Summit Medical Group Primaquine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Summit Medical Group Primaquine Product Portfolio
  18. 8.3.5 Summit Medical Group Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Primaquine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Primaquine Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Primaquine Value Chain Analysis
  2. 9.1.1 Primaquine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Primaquine Sales Mode & Process
  6. 9.2 Primaquine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Primaquine Distributors
  9. 9.2.3 Primaquine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst